Cytokine gene expression in the BB rat pancreas: Natural course and impact of bacterial vaccines

Diabetologia

Volumn 39, Issue 12, 1996, Pages 1448-1454

  Kolb, H ^a,c   Worz Pagenstert U ^a   Kleemann, R ^a   Rothe, H ^a   Rowsell, P ^b   Scott, F W ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HEALTH CANADA   (Canada)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

BB rat; BCG; cytokines; inducible NO synthase; insulitis; lipopolysaccharide; tetanus toxoid

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; CYTOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; OM 89; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INSULITIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS; PRIORITY JOURNAL; RAT; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL VACCINES; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIPHTHERIA TOXOID; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MYCOBACTERIUM BOVIS; NITRIC OXIDE SYNTHASE; PANCREAS; RANDOM ALLOCATION; RATS; RATS, INBRED BB; RATS, WISTAR; REGRESSION ANALYSIS; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; TETANUS TOXOID; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029955383     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050597     Document Type: Article

References (41)

1. Shehadeh NN, La Rosa F, Lafferty KJ (1993) Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmunity 6: 291-300
2. Rabinovitch A (1994) Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 43: 613-621
3. Rothe H, Faust A, Schade U et al. (1994) Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 37: 1154-1158
4. Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Rajotte RV, Bleackley RC (1994) Analysis of cytokine mRNA expression in syngenic islet grafts of NOD mice: interleukin-2 and interferon-gamma mRNA expression correlate with graft rejection and interleukin-10 with graft survival. Diabetologia 37: 833-845
5. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB (1993) Insulin-dependent diabetes in the NOD mouse model II β cell destruction in the autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity 15: 113-122
6. Campbell IL, Kay TWH, Oxbrow L, Harrison LC (1991) Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87: 739-742
7. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin-12 administration induces T helper cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181: 817-821
8. Rothe M, Burkart V, Faust A, Kolb H (1996) Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 39: 119-122
9. Harada M, Kishimoto Y, Makino S (1990) Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Prac 8: 85-89
10. Sadelain MWJ, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes in NOD mice by adjuvent immunotherapy. Diabetes 39: 583-589
11. McInerney MF, Pek SB, Thomas DW (1991) Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40: 715-725
12. Uleato D, Lacy PE, Kipnis DM, Kanagawa O, Unanue ER (1992) A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc Natl Acad Sci 89: 3927-3931
13. Katz JD, Benoist C, Mathis D (1995) T helper subsets in insulin-dependent diabetes. Sciences 268: 1185-1188
14. Seemayer TA, Tannenbaum GS, Goldmann H, Colle E (1982) Dynamic time course studies of the spontaneously diabetic BB Wistar rat. Am J Pathol 106: 237-249
15. Logothetopoulos J, Valiquette N, Madura E, Cvet D (1984) The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic young adult BB rat studied by pancreatic biopsy. Diabetes 33: 33-36
16. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H (1989) Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic lesions of prediabetic BB rats. Diabetologia 32: 126-134
17. Walker R, Bone AJ, Cooke A, Baird JD (1988) Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats. Diabetes 37: 1301-1304
18. Ku L, Kim MK, Amano K, Pak CY, Jaworski MA, Mehta JG, Yoon J-W (1989) Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes 37: 1053-1058
19. Voorbij HAM, Jeucken PHM, Kabel PJ, de Haan M, Drexhage HA (1989) Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 38: 1623-1629
20. Bone AJ, Walker R, Varey A-M, Cooke A, Baird JD (1990) Effect of cyclosporin on pancreatic events and development of diabetes in BB/Edinburgh Rats. Diabetes 39: 508-514
21. Ziegler A-G, Erhard J, Lampeter EF, Nagelkerken LM, Standl E (1992) Involvement of dendritic cells in early insulitis of BB rats. J Autoimmunity 5: 571-579
22. Satoh J, Shintani S, Oya K, Tanaka S-I, Nobunaga T, Toyota T, Goto Y (1988) Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 37: 1188-1194
23. Sadelain MWJ, Qin H-Y, Sumoski W, Parfrey N, Singh B, Rabinovitch A (1990) Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmun 3: 671-680
24. Kiesel U, Farine J-C, Kolb H (1994) Prevention of diabetes in BB rats by an E. coli extract (OM-89). Int J Immunopathol Pharmacol 7: 193-404
25. Kleemann R, Rothe H, Kolb-Bachofen V et al. (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett 328: 9-12
26. Suschek C, Fehsel K, Kröncke K-D, Sommer A, Kolb-Bachofen V (1994) Primary cultures of rat islet capillary endothelial cells. Am J Pathol 145: 685-695
27. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD (1994) A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 177: 23-28
28. Kolb-Bachofen V, Epstein S, Kiesel U, Kolb H (1988) Low-dose streptozotocin-induced diabetes in mice. Diabetes 37: 21-27
29. Kolb-Bachofen V, Schraermeyer U, Hoppe T, Hanenberg H, Kolb H (1992) Diabetes manifestation in BB rats is preceded by panpancreatic presence of activated inflammatory macrophages. Pancreas 7: 578-584
30. Huang X, Hultgren B, Dybdai N, Stewart TA (1994) Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1: 469-478
31. Löhr M, Markholst H, Dyrberg T, Klöppel G, Oberholzer M, Lernmark A (1989) Insulitis and diabetes are preceded by a decrease in β-cell volume in diabetes-prone BB rats. Pancreas 4: 95-100
32. Gepts W, LeCompte M (1985) The pathology of type I (juvenile) diabetes. In: Volk BW, Arquilla EA (eds). The diabetic pancreas. Plenum Publishing Corporation, New York pp. 337-365
33. Somoza N, Vargas F, Roura-Mir C et al. (1994) Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J Immunol 153: 1360-1365
34. Jiang Z, Woda BA (1991) Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J Immunol 146: 2990-2994
35. Powrie F, Coffman RL (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 14: 270-274
36. Zipris D, Greiner DL, Malkani S, Whalen B, Mordes JP, Rossini AA (1996) Cytokine gene expression in islets and thyroids of bb rats. J Immunol 156: 1315-1321
37. Katsikis PD, Cohen SBA, Londei M, Feldmann M (1995) Are CD4(+) T(h)1 cells pro-inflammatory or antiinflammatory? The ratio of interleukin-10 to interferon-gamma or interleukin-2 determines their function. Int Immunol 7: 1287-1294
38. Kallmann B, Hüther M, Bertrams J, Gries FA, Lampeter EF, Kolb H (1995) A bias towards Th1 activity in the peripheral blood of recent onset type I diabetic patients. Autoimmunity 21: 52 (Abstract)
39. Kallmann BA, Kolb H, Hüther M, Martin S, Heilermann M, Lampeter EF (1996) Interleukin-10 is a predominant cytokine in atopic dermatitis. Arch Dermatol, in press
40. Peters DH, Goa KL (1994) OM-8980 An initial review of its pharmacology and therapeutic potential in rheumatoid arthritis. Clin Immunother 2: 65-67
41. Polla BS, Baladi S, Fuller K, Rook G (1995) Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance? Experientia 51: 775-779